INTRODUCTION
Insulin secretion by the , cells of the islets of Langerhans is exquisitely sensitive to subtle changes in the circulating blood glucose concentration. This effect is dependent on the uptake and metabolism of glucose (Ashcroft, 1980) . Glucose also stimulates insulin biosynthesis, in the short term through effects on the rate of translation of pre-existing mRNA molecules, and in the long term through effects on the half-life of insulin mRNA and on insulin gene transcription (Docherty and Clark, 1994) .
Transcription of the insulin gene is dependent on the interaction between nuclear factors and cis-acting elements located within 350 bp upstream from the mRNA start site (Walker et al., 1983) . Most of the studies on the transient hormonal or nutritional control of insulin gene transcription have been performed on the rat insulin I gene (there are two non-allelic insulin genes in the rat). Our own studies have focused on the human insulin gene. Although the two rat insulin genes and the human insulin gene show around 70% sequence similarity in their 5' upstream region, there are substantial differences in the organization of regulatory sequences between the three genes (Clark and Docherty, 1992) . A number of transcription factors that bind to discrete sequences in the human insulin gene upstream region have been described. The f8-cell-specific factor, IUFI (insulin upstream factor 1) binds to the sequence T(C/T)TAATG at three sites, -77 (the CT1 box), -210 (the CT2 box), and at -315 (the CT3 box) (Boam and Docherty, 1989) . The helixloop-helix (HLH) factor IEFI (insulin enhancer factor I) (Karlsson et al., 1987) binds to an E box (consensus sequence 15 min. This effect was dependent on glucose metabolism as it was inhibited by mannoheptulose. Incubation of islets for 4 h in low concentrations of glucose supplemented with phosphatase inhibitors prevented the fall in IUFI activity. No recovery in IUFI activity was observed when islets were treated for 4 h with low glucose and then for a further 1 h with low glucose and dibutyryl cyclic AMP, or forskolin, or the phorbol ester phorbol 12-myristate 13-acetate. These results demonstrate that the IUFIbinding activity in islets of Langerhans is modulated by glucose in a phosphorylation-dependent manner, and that protein kinase A or protein kinase C are not involved. Finally, IUFI was shown to be immunologically related to a recently cloned factor, IPF1, that binds to a CT-like sequence in the rat insulin I gene promoter.
CANNTG) located at -103 (the IEBI box). A second HLH factor USF (upstream stimulating factor) binds along with a second uncharacterized factor D2 to a sequence at -232 (the IEB2 box) . The role of these sequences and a powerful negatively acting element at around -258 (Boam et al., 1990a) in regulating transcription of the human insulin gene have yet to be fully established.
The mechanisms whereby glucose regulates transcription of the insulin gene are not well understood. In the rat insulin I gene, sequences located between -196 and -247 have been shown to mediate the response to glucose (German et al., 1990) . This region, which is known as the FLAT element, binds a number of transcription factors that contain a homeodomain (German et al., 1992b) . The binding ofone uncharacterized factor, designated Cl, to this region was shown to be modulated by glucose in isolated rat and human islets of Langerhans (Melloul et al., 1993) . Given that the FLAT element lies at an equivalent position in the rat insulin I gene to the CT2 element of the human insulin gene, the present study was (Montague and Taylor, 1968) and were prepared in Gey and Gey medium (Gey and Gey, 1936) using a modification of the method of Hurst and Morgan (1990) . Each experimental sample contained 120-150 islets, and all incubations were performed at 37°C in Hanks' balanced salt solution. In some experiments a cocktail of phosphatase inhibitors (1O mM NaF, 10 mM sodium molybdate, 10 mM f,-glycerophosphate, 10 mM sodium vanadate, and 10 mM pnitrophenyl phosphate) was added.
Preparation of nuclear extracts
Nuclear extracts were prepared using a modification of the method of Schreiber et al. (1989) . Islets were centrifuged for 10 s in a microcentrifuge and resuspended in 400 ,ul of 10 mM Hepes, pH 7.9, containing 10 mM KCI, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 0.5 mM phenylmethanesulphonyl fluoride, 10 mM NaF, 10 mM sodium molybdate, 10 mM ,-glycerophosphate, 10 mM sodium vanadate, and 10 mM p-nitrophenyl phosphate. Islets were allowed to swell for 15 min on ice before adding 25 ,u of 10 % (v/v) Nonidet NP-40. The islets were then vortexed for 15 s and centrifuged for 30 s in a microcentrifuge. The pellet, which was enriched in nuclei, was resuspended in 50 ,u1 of 20 mM Hepes, pH 7.9, containing 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethanesulphonyl fluoride, 10,tg/ml leupeptin, 1 ,ug/ml pepstatin A, 0.1 mM p-aminobenzoic acid, 10 ,ug/ml aprotinin, 5 % (v/v) glycerol, 10 mM NaF, 10 mM sodium molybdate, 10 mM /J-glycerophosphate, 10 mM sodium vanadate and 10 mM pnitrophenyl phosphate. Nuclear extracts were then centrifuged for 2 min at 4°C in a microcentrifuge. The supernatant was collected, aliquoted into small volumes and stored at -70 'C.
Oligonucleotides
Oligonucleotides were purchased from Alta Bioscience (University of Birmingham, Birmingham, U.K.). Single-stranded complementary oligonucleotides were annealed as previously described (Boam et al., 1990b) , and labelled with [y-32P]ATP using T4 polynucleotide kinase.
Electrophoretic mobility shfft assays (e.m.s.a.) E.m.s.a. were performed as previously described (Boam et al., 1990b) . Nuclear extracts (0.5 ,ug of protein), were incubated with radiolabelled probe for 20 min at room temperature in buffer containing 10 mM Tris/HCI, pH 7.5, 50 mM KC1, 5 mM dithiothreitol, 1 mM EDTA and 5 % (v/v) glycerol. For competition experiments, the nuclear extract was incubated with 2.5 pmol (approx. 50-fold excess) of unlabelled oligonucleotide for 20 min at room temperature before addition of the probe. In some experiments nuclear extracts were treated with 1 x 10-3 unit of potato acid phosphatase for 30 min at 37 'C.
Western blots
The mouse pancreatic cell lines, aTCI and ,TC3 were derived from transgenic mice expressing the simian virus 40 (SV40) large T antigen under the control of either the glucagon or insulin promoter respectively. HIT TI 5's are a hamster insulin-secreting cell line while HeLa and BHK cells are non-insulin-secreting cells. For Western-blot analysis, 5 ,ug samples of nuclear extract from each of the cell lines were fractionated by SDS/PAGE, and blotted on to Immobilon-P transfer membrane (Millipore) and incubated for 60 min in buffer [10 mM Tris/HCl, 0.05 0/ (v/v) Tween 20 and 0.5 M NaCI] containing a 1: 1000 dilution of anti-IPFI antibody. The antibody-antigen complex was detected by incubating the membrane for a further 60 min in buffer containing a 1:10000 dilution of horseradish peroxidase-conjugated anti-(rabbit IgG) secondary antibody (ECL-Amersham).
RESULTS
The transcription factor IUFI binds to three sites in the human insulin gene enhancer (the CT boxes) (Figure 1 ). The role of IUFI binding at each of these sites is unknown, although there The boxes on the line represent discrete regulatory squences with their position relative to the transcription start site indicated as negative numbers. Proteins that bind to these sites are shown above each box. Further details of how these sites, along with the GG1 (-128) and GG2 (-139) boxes which are not included in -the above schematic diagram, were characterized are provided in Docherty (1992 S Freshly isolated rat islets of Langerhans were incubated for 4 h in medium containing 20 mM glucose (H4) or 3 mM glucose (L4). Batches of islets were also incubated for 3 h in medium containing: 3 mM glucose and then for 1 h in medium containing 20 mM mannoheptulose (L3M); 3 mM glucose and 20 mM mannoheptulose and then for 1 h in medium containing 20 mM glucose (L3MH); and in medium containing 3 mM glucose and then for 1 h in medium containing 20 mM glucose (L3H). Nuclear extracts were then prepared, and the IUFl-binding activity analysed by e.m.s.a. using oligonucleotide B as probe.
is some evidence that the CT2 box may act synergistically with the adjacent IEB2 box to regulate transcription of the gene (M. L. Read and K. Docherty, unpublished work). IUF1-binding activity in the rat islets was initially confirmed by competition assay using three double-stranded 30-mer oligonucleotides corresponding to sequences within the human insulin gene enhancer region; oligonucleotide B 5'-CCCCTGGTT AAGACTCTAATGACCCGCTGG-3', which contains a functional IUF1-binding site (CT2 box) (underlined); and two competitor oligonucleotides, Bm I 5'-CCCCTGGTAAGA CCCTAATGACCCGCTGG-3' which contains a T/C transversion which does not affect IUFI binding; and Bm2 5'-CCCCTGGTTAAGACTCTACTGACCCGCTGG-3' containing an A/C transversion known to abolish IUF1-binding activity (Boam and Docherty, 1989) . Using a nuclear extract from rat islets of Langerhans and oligonucleotide B as probe, a number of retarded bands were observed (Figure 2, lane 1) . The major slowmobility band represents IUFI-binding activity, while the fastestmigrating minor band represents an IUFI breakdown product. Formation of these retarded bands was abolished by oligonucleotide Bml but not by Bm2, confirming that these bands represented specific binding to the CT2 box in oligonucleotide B.
Further proof that these bands represented IUFI binding was provided by the observation that binding occurred at high salt (400 mM NaCl) concentrations, a characteristic of IUFI.
To determine the effect of glucose on IUFI-binding activity, rat islets of Langerhans were incubated for periods of time in buffer containing low (3 mM) or high (20 mM) glucose concentrations and IUFl-binding activity measured by e.m.s.a. using oligonucleotide B as probe (Figure 3) . In 3 mM glucose the IUFI-binding activity remained unchanged after incubation for I h. After incubation for 3 h, the IUF1-binding activity had declined considerably such that by 6 h very little activity remained. After 24 h there was no detectable IUF 1-binding activity. In islets incubated in 20 mM glucose, IUF1-binding activity was unaffected after 6 h, and only declined slightly after 24 h.
Islets were incubated for 4 h in 3 mM glucose, and then transferred to medium containing 20 mM glucose (Figure 4) . After 4 h in 3 mM glucose the IUF1-binding activity was undetectable (Figure 4 , lane 2). When the islets were then transferred from buffer containing 3 mM glucose to buffer containing 20 mM glucose, IUF 1-binding activity was observed after 10 min, with full recovery of activity after 15 min (Figure 4 , lane 6). To determine whether glucose metabolism was required for this stimulatory effect, islets were preincubated in 3 mM glucose for 4 h and then exposed to 20 mM glucose in the presence of the glycolysis inhibitor mannoheptulose ( Figure 5) . Mannoheptulose inhibited the increase in IUFl-binding activity when the islets were transferred to high glucose concentrations. These results indicate that glucose modulates the binding activity of IUFI by way of reversible and rapid modification of the protein, and that this effect involved metabolism of glucose.
Further evidence supporting a glucose-induced post-translational modification of IUF 1 came from an experiment in which rat islets of Langerhans were incubated in medium containing 3 mM glucose for 3 or 4 h in the presence and absence of an additional cocktail of phosphatase inhibitors (Figure 6a ). Inhibition of islet phosphatase activity prevented the decrease in IUFl-binding activity seen in islets incubated in 3 mM glucose. Also, treatment of a nuclear extract from islets incubated for 4 h in 20 mM glucose with potato acid phosphatase resulted in a complete removal of IUFI activity (Figure 6b ). That this was a specific effect of the phosphatase was confirmed by performing the phosphatase reaction in the presence of a phosphatase inhibitor cocktail. Under these conditions the IUFl activity was unaffected (Figure 6b, lane 3) . The buffer used in the phosphatase reaction had no effect on the e.m.s.a. (Figure 6b, lane 4) .
To investigate whether glucose modulation of IUFI-binding activity involved protein kinase A, islets were incubated for 3 h in 3 mM glucose then transferred to medium containing 20 mM glucose or 3 mM glucose supplemented with dibutyryl cyclic AMP (db cyclic AMP). Over the range I to 20 mM, db cyclic AMP had no effect on the low IUFI-binding activity observed following incubation in 3 mM glucose (Figure 7a ). Forskolin at 10 ,uM and 25 ,uM also had no effect on IUFI-binding activity, lending support to the conclusion that protein kinase A was not involved in modulating IUFl-binding activity (Figure 7b ). The phorbol ester phorbol 12-myristate 13-acetate (PMA) had no effect on the low IUFl-binding activity in islets incubated in 3 mM glucose (Figure 7c ), indicating that protein kinase C was the medium at concentrations of 10 and 20 mM calcium had no effect (Figure 8) . We have previously shown that IUFI binds to a CT-like sequence in the promoter region of the rat insulin I gene . Ohlsson et al. (1993) have recently cloned a cDNA encoding a factor, IPF1, that binds to this site. In order to determine whether IUFI and IPF1 were related, we used an antibody raised against a sequence from mouse IPF1 in e.m.s.a. and Western-blot analyses. The antibody was shown to abolish IUF1-binding activity in a nuclear extract from the mouse /ITC3 cell line, while non-immune serum had no effect (Figure 9a) . The antibody detected a specific 46 kDa protein in the mouse pTC3 cell line and in the hamster HIT T15 ,-cell line, but not in the mouse aTC1 cell line nor in BHK or HeLa cells (Figure 9b ).
DISCUSSION
In the present study, we have shown that the fl-cell-specific transcription factor IUF1 binds to the insulin gene enhancer region in a glucose-responsive manner, and furthermore that changes in the binding activity of the protein occur as a result of an active modulation of its phosphorylation state. This is the first study, that we are aware of, linking glucose metabolism with the phosphorylation status of a specific transcription factor, and represents an important step in an understanding of how nutrients control gene expression.
In the rat insulin I gene a glucose response element has been mapped to a location between nucleotides -196 to -247 upstream of the transcription start site (German et al., 1990 ). Melloul et al. (1993 further mapped the element to sequences -193 to -227 that contained the FLAT element. This element binds a number of homeodomain proteins including lmx-1, cdx-3 (German et al., 1992b) , Isll (Karlsson et al., 1990) , and the liver-enriched protein HNFla (Emens et al., 1992) . It also binds at least two other uncharacterized factors, namely factor Cl (Melloul et al., 1993) and IEF2 (Ohlsson et al., 1991) . Of these factors, the binding of C I to its cognate site in the FLAT element is modulated by glucose in both rat and human islets of Langerhans (Melloul et al., 1993) . It is likely that IUFI and factor Cl are the same proteins; they are f-cell-specific, their binding activities are modulated by glucose, and they bind to similar sequences in the insulin gene.
A factor, IPFI, that binds to a CT-like sequence at position -77 in the rat insulin I promoter has recently been cloned (Ohlsson et al., 1993) . CT-like sequences are also located in the rat islet amyloid polypeptide gene, the fl-cell glucokinase gene promoter, and in the somatostatin gene promoter . The CT-like sequence in the glucokinase gene promoter binds IUFI as shown by e.m.s.a. competition assays (Shelton et al., 1992) . In the somatostatin promoter the CT-like element binds a factor called STF1, which has also recently been cloned (Leonard et al., 1993 (German et al., 1992a) . The FAR element binds a HLH factor IEFl, that is a heterodimer of the ubiquitously expressed E2A gene product E12/E47 (also known as shPanl and shPan2) (Shibasaki et al., 1990; Walker et al., 1990; German et al., 1991) and an HLH factor IESFI which exhibits a more restricted tissue distribution (Park and Walker, 1992) . A direct interaction between a fl-cell homeodomain factor lmx-1, bound at the FLAT element, and the E47 component of IEFI, bound at the FAR element, has been demonstrated (German et al., 1992b) . It is not clear whether this combinatorial interaction between adjacent sites is required for the full glucose effect on transcription, although the data of Melloul et al. (1993) would suggest that the FLAT element on its own is sufficient to confer a transcriptional response to glucose. In the human insulin gene the CT2 box (-210) lies adjacent to the FAR-equivalent sequence (the IEB2 box) at -232 that binds with high affinity the HLH transcription factor USF (upstream stimulatory factor) . Another factor binds to the sequence GGGCCC that lies adjacent to the USF-binding site (Reibel et al., 1993) . Our preliminary data suggest that the CT2 box and the adjacent IEB2 element only exhibit transcriptional activity when in combination, and that IUFI is a component of a multiprotein DNA-binding complex (M. L. Read and K. Docherty, unpublished work) . It is thus of interest that in the L-type pyruvate kinase-gene, USF acts in combination with factors binding at adjacent sequences to confer a transcriptional response to glucose (Bergot et al., 1992; Diaz-Guerra et al., 1993) . The L-type pyruvate kinase and insulin genes are both regulated at the transcriptional level by glucose in pancreatic , cells, although there are subtle differences in the response (Marie et al., 1993) . This suggests a possible involvement of IUFI binding at the CT2 site and USF at the IEB2 site in the glucose regulation of insulin gene transcription. -Missotten, 1990 ). Thus we suggest that there are two pathways controlling insulin gene transcription: one involving changes in intracellular cyclic AMP which mediates an effect through the CRE, and a second involving nutrient metabolism which involves phosphorylation/dephosphorylation of IUF 1 by way of a yet to be identified signalling pathway (Docherty and Clark, 1994) .
In the present study extracellular calcium had no effect on IUF1-binding activity. The role of calcium in the regulation of insulin gene transcription is unclear. One study reported an effect of calcium on insulin gene transcription in fetal rat islets of Langerhans (German et al., 1990) , while a second 'reported no effect in the HIT T15 cell line (Goodison et al., 1992) .
A defect in IUF 1-binding activity may be important in type-Il or non-insulin-dependent diabetes mellitus (NIDDM). Olson et al. (1993) have shown that chronic exposure of HIT T15 cells to high glucose concentrations results in decreased insulin gene transcription and decreased binding activity of a factor, glucosesensitive transcription factor (GSTF), that binds to the CT box of the human insulin gene, and which, based on e.m.s.a. competition studies, is similar to IUFI (Olson et al., 1993) . This suggests that one of the fl-cell defects associated with hyperglycaemia as seen in patients with NIDDM may be related to downregulation of IUF 1-binding activity. The recent cloning of its cDNA may allow detailed investigation of the mechanisms involved, and establish through family linkage or association studies the role of the IUFI/IPFl/STFl/factor C/GSTF gene(s?) in the inheritance of NIDDM.
